Radiomic features predict Ki-67 expression level and survival in lower grade gliomas

J Neurooncol. 2017 Nov;135(2):317-324. doi: 10.1007/s11060-017-2576-8. Epub 2017 Sep 12.

Abstract

To investigate the radiomic features associated with Ki-67 expression in lower grade gliomas and assess the prognostic values of these features. Patients with lower grade gliomas (n = 117) were randomly assigned into the training (n = 78) and validation (n = 39) sets. A total of 431 radiological features were extracted from each patient. Differential radiological features between the low and high Ki-67 expression groups were screened by significance analysis of microarrays. Then, generalized linear analysis was performed to select features that could predict the Ki-67 expression level. Predictive efficiencies were further evaluated in the validation set. Cox regression analysis was performed to investigate the prognostic values of Ki-67 expression level and Ki-67-related radiological features. A group of nine radiological features were screened for prediction of Ki-67 expression status; these achieved accuracies of 83.3% and 88.6% (areas under the curves, 0.91 and 0.93) in the training and validation sets, respectively. Of these features, only spherical disproportion (SD) was found to be a prognostic factor. Patients in the high SD group exhibited worse outcomes in the whole cohort (overall survival, p < 0.0001; progression-free survival, p < 0.0001). Ki-67 expression level and SD were independent prognostic factors in the multivariate Cox regression analysis. This study identified a radiomic signature for prediction of Ki-67 expression level as well as a prognostic radiological feature in patients with lower grade gliomas.

Keywords: Ki-67; Lower grade gliomas; Prediction; Radiogenomics; Survival.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Area Under Curve
  • Biomarkers, Tumor / metabolism
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Brain / pathology
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Female
  • Glioma / diagnostic imaging*
  • Glioma / metabolism*
  • Glioma / pathology
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism*
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Grading
  • Prognosis
  • ROC Curve
  • Survival Analysis
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen